PM

A strong legacy business and bright future combine to make Philip Morris a no-brainer for dividend investors.

Both of these threats have the same roots: private entities seeking to cash in.

NEW YORK, Oct. 26, 2026 /PRNewswire/ -- AVANT BIO LLC, the growth equity firm investing in life science industrials and enabling technologies, today announced the appointment of Peggy Lio and Philip Vanek, Ph.D., as Operating Advisors.

Philip Morris International reported third quarter 2026 sales of US$11.4b with net income of US$3.3b, while smoke free products and margin expansion supported what management described as strong results and an upgraded full year adjusted EPS outlook.

Philip Morris International (NYSE:PM) has warned that ongoing global conflicts are disrupting parts of its business operations. Management said these geopolitical events are clouding its earnings outlook and adding uncertainty to future financial performance.

Philip Morris delivered better-than-expected Q3 results, but geopolitical risks remain. Discover ETFs with significant exposure to the company.

Philip Morris maintains its 2026 earnings outlook despite geopolitical costs, as rising ZYN investments and smoke-free expansion pressure U.S. profitability.

Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q3 2026, with sales up 5.5% year on year to $11.44 billion. Its non-GAAP profit of $2.36 per share was 1.9% above analysts’ consensus estimates.

Philip Morris International (PM:NYSE) beat third-quarter estimates on October 21, and the stock still slipped. Adjusted EPS came in at $2.

The company is sacrificing near-term margins to defend its nicotine pouch dominance while traditional cigarettes fund the shift.

Moby summary of Philip Morris International Inc.'s Q3 2026 earnings call